Marquette Asset Management, LLC
Position in MGX — Metagenomi Therapeutics, Inc.
CIK 1395067
MINNEAPOLIS, MN
Position in MGX
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$85,823
-$98,575 QoQ
Shares Held
72,121
+41.2% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in MGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Marquette Asset Management, LLC holds $1,528,077 across 29 Biotechnology names. MGX ranks #8 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCYC |
Bicycle Therapeutics PLC
|
72,854 | $308,900 | |
| 2 | ENGN |
enGene Therapeutics Inc.
|
150,546 | $260,444 | |
| 3 | NKTX |
Nkarta, Inc.
|
75,071 | $212,450 | |
| 4 | PLRX |
Pliant Therapeutics, Inc.
|
174,500 | $198,930 | |
| 5 | FULC |
Fulcrum Therapeutics, Inc.
|
38,552 | $141,100 | |
| 6 | ZNTL |
Zentalis Pharmaceuticals, Inc.
|
28,973 | $140,519 | |
| 7 | SEER |
Seer, Inc.
|
61,816 | $102,614 | |
| 8 | MGX |
Metagenomi Therapeutics, Inc.
This page
|
72,121 | $85,823 |
All Filings in MGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,823 | 72,121 | Shares | Sole | 2026-07-09 | |
| 2024-12-31 | $184,398 | 51,080 | Shares | Sole | 2025-01-14 | |
| No filing history on record for this holder in this stock. | ||||||